Event to be held October 14th at 4 p.m. EST October 09, 2025 07:00 ET | Source: Gain Therapeutics, Inc.…
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants Secondary…
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage…
Wednesday 11 June, 2025 The Chilterns Neuro Centre is delighted by the success of its Charity Golf Day, held at…